[Frontiers In Bioscience, Landmark, 24, 1060-1070, March 1, 2019]

BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression

Xiangdong Zhao1,2, Qian Sun1,3, Changwu Dou2, Qianxue Chen1,3, Baohui Liu1,3

1Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China, 2Department of Neurosurgery, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, Inner Mongolian Autonomous Region, China, 3Central laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China


1. Abstract
2. Introduction
3. Materials and methods
3.1. Reagents
3.2. Tissue samples
3.3. Immunohistochemical staining
3.4. Cell culture and transfection
3.5. Reverse transcription polymerase chain reaction
3.6. Western blotting
3.7. Establishment of a stable GBM cell line with high BMP4 expression for tumor implantation
3.8. Scratch wound and transwell assays
3.9. Statistical analysis
4. Results
4.1. BMP4 expression positively correlates with E-cadherin and claudin expression in human GBM
4.2. BMP4 negatively regulates GBM cell invasion in vitro
4.3. Forced expression of BMP4 inhibits GBM cell invasion in the nude mouse brain
4.4. BMP4 inhibits GBM cell invasion via promotion of Smad1/5/8 protein phosphorylation
5. Discussion
6. Acknowledgments
7. References


Glioblastoma multiforme (GBM) is a brain tumor that deeply infiltrates adjacent tissues and causes significant mortality. Thus, understanding the mechanisms that derive the invasion of brain tissue by GBM might help the treatment of this cancer. To this end, we examined the impact of BMP4 on invasion of GBM. In this study, Human GBM samples, GBM cells and human orthotopic GBM-xenografted animal model, quantitative PCR, immunostaining, immunoblotting, Scratch wound and transwell assays were used to detect the effect and the mechanism of BMP4 in GBM cells. BMP4 expression was found to positively correlate with E-cadherin and claudin expression in human GBM samples. Elevation or suppression of BMP4 expression resulted in a respective increase or decrease in E-cadherin and claudin levels, both in vitro and in vivo. Suppression of BMP4 expression was associated with enhanced GBM cell migration and invasion, while BMP4 overexpression inhibited these processes. Smad1/5/8 protein phosphorylation positively correlated with BMP4 expression. Pharmacological blockade of Smad1/5/8 phosphorylation impaired BMP4-dependent inhibition of cell migration and invasion. Together, these findings suggest that BMP4 increases E-cadherin and claudin expression in GBM through activation of SMAD signaling, thereby suppressing tumor cell invasion.


1. Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S, Manzotti G, Grisendi G, Dominici M, Pieraccioli M, Raschella G, Chiodoni C, Colombo MP, and Calabretta B: Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. Cancer Res73 (1), 235-245 (2013)
DOI: 10.1158/0008-5472.CAN-12-1739

2. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, and Rich JN: Molecularly targeted therapy for malignant glioma. Cancer110 (1), 13-24 (2007)

3. Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer3 (7), 489-501 (2003)
DOI: 10.1038/nrc1121

4. Sakou T: Bone morphogenetic proteins: from basic studies to clinical approaches. Bone22 (6), 591-603 (1998)

5. Sathornsumetee S, and Rich JN: New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther6 (7), 1087-1104 (2006)
DOI: 10.1586/14737140.6.7.1087

6. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, and Wang EA: Novel regulators of bone formation: molecular clones and activities. Science242 (4885), 1528-1534 (1988)

7. Liu B, Tian D, Yi W, Wu L, Cai Q, Dong H, Shen H, Ji B, Wang L, Zhang S, Ruan D, and Chen Q: Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251. Cell Biochem Biophys58 (2), 91-96 (2010)
DOI: 10.1007/s12013-010-9095-y

8. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, and Vescovi AL: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature444 (7120), 761-765 (2006)

9. Su D, Zhu S, Han X, Feng Y, Huang H, Ren G, Pan L, Zhang Y, Lu J, and Huang B: BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells. J Biol Chem284 (18), 12153-12164 (2009)
DOI: 10.1074/jbc.M807930200

10. Guo D, Huang J, and Gong J: Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. Mol Cell Biochem363 (1-2), 179-190 (2012)
DOI: 10.1007/s11010-011-1170-1

11. Serrao A, Jenkins LM, Chumanevich AA, Horst B, Liang J, Gatza ML, Lee NY, Roninson IB, Broude EV, and Mythreye K: Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene37 (35), 4792-4808 (2018)

12. Cao X, Xu L, Liu Q, Yang L, Li N, and Li X: MicroRNA-1277 inhibits proliferation and migration of hepatocellular carcinoma HepG2 cells by targeting and suppressing BMP4 expression and reflects the significant indicative role in hepatocellular carcinoma pathology and diagnosis after magnetic resonance imaging assessment. Oncol Res (2018)
DOI: 10.3727/096504018X15213058045841

13. Liu B, Chen Q, Tian D, Wu L, Dong H, Wang J, Ji B, Zhu X, Cai Q, Wang L, and Zhang S: BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma. Brain Res1507115-124 (2013)
DOI: 10.1016/j.brainres.2013.02.039

14. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, and Ellison DW: The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol131 (6), 803-820 (2016)
DOI: 10.1007/s00401-016-1545-1

15. Liu B, Dong H, Lin X, Yang X, Yue X, Yang J, Li Y, Wu L, Zhu X, Zhang S, Tian D, Wang J, Cai Q, Mao S, Chen Q, and Chang J: RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion. Oncotarget7 (50), 82411-82423 (2016)

16. Kaye AH, Morstyn G, Gardner I, and Pyke K: Development of a xenograft glioma model in mouse brain. Cancer Res46 (3), 1367-1373 (1986)

17. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med352 (10), 987-996 (2005)
DOI: 10.1056/NEJMoa043330

18. Jain RK: Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed Eng1241-263 (1999)
DOI: 10.1146/annurev.bioeng.1.1.241

19. Jain RK: Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev64 (Suppl), 353-365 (2012)
DOI: 10.1016/j.addr.2012.09.011

20. Rahman M, Azari H, Deleyrolle L, Millette S, Zeng H, and Reynolds BA: Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma. Future Oncol9 (9), 1389-1396 (2013)
DOI: 10.2217/fon.13.96

21. Helbing T, Arnold L, Wiltgen G, Hirschbihl E, Gabelmann V, Hornstein A, Esser JS, Diehl P, Grundmann S, Busch HJ, Fink K, Bode C, and Moser M: Endothelial BMP4 Regulates Leukocyte Diapedesis and Promotes Inflammation. Inflammation40 (6), 1862-1874 (2017)

22. Hai Y, Sun M, Niu M, Yuan Q, Guo Y, Li Z, and He Z: BMP4 promotes human Sertoli cell proliferation via Smad1/5 and ID2/3 pathway and its abnormality is associated with azoospermia. Discov Med19 (105), 311-325 (2015)

Abbreviations: GBM, glioblastoma multiforme; BMP4, bone morphogenetic proteins 4; BMPs, bone morphogenetic proteins; TGF-β, transforming growth factor-β

Key Words: Glioblastoma Multiforme, Invasion, BMP4, pSmad1/5/8, E-cadherin, Claudin

Send correspondence to: Qianxue Chen, Department of Neurosurgery, Renmin Hospital of Wuhan University, 238 Jiefang Street, Wuhan, 430060, Hubei, China, Tel: 86-136-0714-1618, Fax: 86-27-8804-2292, E-mail: chenqx666@whu.edu.cn.